DrugsControl Media Services

News Detail

Bayer's Aflibercept injection gets DCGI nod for Diabetic Macular Edema indication (23-09-2020)

NEW DELHI, 22 SEPT 2020: Life sciences firm Bayer in India on Tuesday said it has received approval from the Drugs Controller General of India (DCGI) for its intravitreal injection Aflibercept, for the treatment of a new indication Diabetic Macular Edema (DME).

DME ......
View Details

Source : Economic Times

Related News